This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Rinvoq
  • /
  • A Study Comparing Upadacitinib (ABT-494) to Placeb...
Clinical trial

A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone (SELECT-NEXT)

Read time: 4 mins
Last updated:17th Dec 2015
Identifier: NCT02675426
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest